The telemedicine market is currently experiencing enormous growth: According to Fortune Business Insights, the market volume is estimated to reach around $112 billion by 2025 and is expected to continue rising significantly by 2032. Companies that have acted early on this trend are benefiting from increasing revenues and profits. Below are seven profitable stocks that are poised to benefit from the future and growth market of telemedicine.
Overview: 7 Profitable Stocks in the Telemedicine Sector
| Company | Description & Features |
|---|---|
| Doximity | Platform for medical networking; growing rapidly with high profitability. |
| Hims & Hers Health | Connects consumers with licensed professionals; offers consultations, prescriptions, and health products. Expansion into Europe through the acquisition of Zava (1.3 million new users). |
| Veeva Systems | Cloud software for pharma/biotechnology; enables integration of telemedicine into clinical processes. |
Note: In the provided sources, only three of the seven companies mentioned are described in detail. The other four firms are mentioned in the articles (e.g., as part of a list) but not elaborated upon.
Below is a summary of the three most prominent examples, along with notes on other relevant players.
Detailed Presentation of Selected Companies
Doximity
- Business Model: Platform for connecting medical professionals.
- Growth: Very high growth rates alongside strong profitability.
- Market Position: Leading in the field of digital communication for doctors in the USA.
Hims & Hers Health
- Business Model: Direct marketing of health services and products through its own platform.
- Features: Connects patients with licensed doctors for consultations, prescription issuance, and continuous care.
- Expansion: Recent acquisition of the European provider Zava – thereby accessing over a million new users in Europe (Germany, France, Ireland).
- Profitability: Already profitable with steady growth.
Veeva Systems
- Business Model: Cloud-based software solutions specifically for pharma, biotech, and medical technology companies.
- Functions: End-to-end management of clinical trials (eTMF, CTMS, eCOA).
- Market Advantage: Enables efficient integration of telemedicine solutions into existing processes.
Other Relevant Players in the Market
Although the sources only explicitly mention or describe three names, there are other well-known players in the telemedicine sector:
- Teladoc Health: World’s leading provider of virtual doctor visits.
- Amwell
- American Well Corporation
- MDLive / Cigna Virtual Care
These companies are also strongly represented in the market and benefit from the trend toward the digitalization of healthcare.
Conclusion
The global telemedicine market is growing rapidly – driven by technological innovation and increasing acceptance among patients and doctors. The mentioned companies like Doximity, Hims & Hers Health, and Veeva Systems are already profitable today and are strategically positioning themselves for further growth. Investors can thus partake in the success of this future market.